DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 64 filers reported holding DERMA SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $36,000 | -73.1% | 6,892 | -75.9% | 0.00% | -100.0% |
| Q3 2016 | $134,000 | +3.9% | 28,608 | -12.5% | 0.00% | 0.0% |
| Q2 2016 | $129,000 | +18.3% | 32,708 | -6.9% | 0.00% | – |
| Q1 2016 | $109,000 | +7.9% | 35,139 | +58.7% | 0.00% | – |
| Q4 2015 | $101,000 | -28.4% | 22,139 | +33.4% | 0.00% | -100.0% |
| Q1 2015 | $141,000 | -13.0% | 16,599 | -4.5% | 0.00% | 0.0% |
| Q4 2014 | $162,000 | +11.7% | 17,390 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $145,000 | -27.1% | 17,390 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $199,000 | +4.7% | 17,184 | +14.7% | 0.00% | 0.0% |
| Q1 2014 | $190,000 | +68.1% | 14,983 | +42.9% | 0.00% | – |
| Q4 2013 | $113,000 | -15.7% | 10,484 | -2.9% | 0.00% | -100.0% |
| Q3 2013 | $134,000 | +4.7% | 10,802 | +12.9% | 0.00% | 0.0% |
| Q2 2013 | $128,000 | – | 9,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |